Spain – Immunosuppressive agents – Supply of exclusive medicines from Argenx Spain S.L. for the Hospital Universitario Fundación Alcorcón to be awarded by negotiated procedure without prior publication
Supply of exclusive medicines from Argenx Spain S.L. for the Hospital Universitario Fundación Alcorcón to be awarded by negotiated procedure without prior publication VYVGART 20 MG/ML concentrate for infusion, 20 ml vial Active substance:
Opportunity description
Supply of exclusive medicines from Argenx Spain S.L. for the Hospital Universitario Fundación Alcorcón to be awarded by negotiated procedure without prior publication VYVGART 20 MG/ML concentrate for infusion, 20 ml vial Active substance: EFGARTIGIMOD ALFA VYVGART 1000 MG/ML, 5.6 ml vial Active substance: EFGARTIGIMOD ALFA Procedure: neg-wo-call. Estimated value: 227,520 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.